Business Description
Luye Pharma Group Ltd
NAICS : 325412
SIC : 2834
ISIN : BMG570071099
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.69 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.73 | |||||
Debt-to-EBITDA | 3.96 | |||||
Interest Coverage | 2.25 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.07 | |||||
Beneish M-Score | -2.52 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.3 | |||||
3-Year EBITDA Growth Rate | -4.4 | |||||
3-Year EPS without NRI Growth Rate | -25.4 | |||||
3-Year Book Growth Rate | 6.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 40.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 9.44 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.17 | |||||
9-Day RSI | 36.99 | |||||
14-Day RSI | 41.97 | |||||
6-1 Month Momentum % | 20 | |||||
12-1 Month Momentum % | -8.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.28 | |||||
Quick Ratio | 1.2 | |||||
Cash Ratio | 0.66 | |||||
Days Inventory | 151.22 | |||||
Days Sales Outstanding | 119.19 | |||||
Days Payable | 137.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.2 | |||||
Shareholder Yield % | 6.81 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 68.74 | |||||
Operating Margin % | 23.1 | |||||
Net Margin % | 12.2 | |||||
FCF Margin % | 8.26 | |||||
ROE % | 6.25 | |||||
ROA % | 2.92 | |||||
ROIC % | 5.55 | |||||
3-Year ROIIC % | -6.2 | |||||
ROC (Joel Greenblatt) % | 25.86 | |||||
ROCE % | 9.93 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 13.14 | |||||
Forward PE Ratio | 10.66 | |||||
PE Ratio without NRI | 14.72 | |||||
Shiller PE Ratio | 10.1 | |||||
Price-to-Owner-Earnings | 57.45 | |||||
PS Ratio | 1.61 | |||||
PB Ratio | 0.79 | |||||
Price-to-Tangible-Book | 1.87 | |||||
Price-to-Free-Cash-Flow | 19.54 | |||||
Price-to-Operating-Cash-Flow | 19.54 | |||||
EV-to-EBIT | 7.98 | |||||
EV-to-Forward-EBIT | 10.07 | |||||
EV-to-EBITDA | 5.55 | |||||
EV-to-Forward-EBITDA | 7.45 | |||||
EV-to-Revenue | 2.08 | |||||
EV-to-Forward-Revenue | 1.73 | |||||
EV-to-FCF | 26.06 | |||||
Price-to-Projected-FCF | 2.12 | |||||
Price-to-Median-PS-Value | 0.52 | |||||
Price-to-Graham-Number | 1.11 | |||||
Earnings Yield (Greenblatt) % | 12.53 | |||||
FCF Yield % | 5.14 | |||||
Forward Rate of Return (Yacktman) % | -14.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Luye Pharma Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 6,852.638 | ||
EPS (TTM) (HK$) | 0.223 | ||
Beta | 1.38 | ||
Volatility % | 37.61 | ||
14-Day RSI | 41.97 | ||
14-Day ATR (HK$) | 0.129048 | ||
20-Day SMA (HK$) | 3.1945 | ||
12-1 Month Momentum % | -8.84 | ||
52-Week Range (HK$) | 2.34 - 4 | ||
Shares Outstanding (Mil) | 3,761.67 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Luye Pharma Group Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Luye Pharma Group Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Luye Pharma Group Ltd Frequently Asked Questions
What is Luye Pharma Group Ltd(HKSE:02186)'s stock price today?
When is next earnings date of Luye Pharma Group Ltd(HKSE:02186)?
Does Luye Pharma Group Ltd(HKSE:02186) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |